» Articles » PMID: 25641057

The Impact of Covariate Adjustment at Randomization and Analysis for Binary Outcomes: Understanding Differences Between Superiority and Noninferiority trials

Overview
Journal Stat Med
Publisher Wiley
Specialty Public Health
Date 2015 Feb 3
PMID 25641057
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The question of when to adjust for important prognostic covariates often arises in the design of clinical trials, and there remain various opinions on whether to adjust during both randomization and analysis, at randomization alone, or at analysis alone. Furthermore, little is known about the impact of covariate adjustment in the context of noninferiority (NI) designs. The current simulation-based research explores this issue in the NI setting, as compared with the typical superiority setting, by assessing the differential impact on power, type I error, and bias in the treatment estimate as well as its standard error, in the context of logistic regression under both simple and covariate adjusted permuted block randomization algorithms. In both the superiority and NI settings, failure to adjust for covariates that influence outcome in the analysis phase, regardless of prior adjustment at randomization, results in treatment estimates that are biased toward zero, with standard errors that are deflated. However, as no treatment difference is approached under the null hypothesis in superiority and under the alternative in NI, this results in decreased power and nominal or conservative (deflated) type I error in the context of superiority but inflated power and type I error under NI. Results from the simulation study suggest that, regardless of the use of the covariate in randomization, it is appropriate to adjust for important prognostic covariates in analysis, as this yields nearly unbiased estimates of treatment as well as nominal type I error.

Citing Articles

The Role of Anticoagulants and Antiplatelets in Reducing Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Studies Reporting Adjusted Data.

Ram M, Umer M, Trada I, Khan S, Imran L, Rehan T Cureus. 2023; 15(9):e45749.

PMID: 37872904 PMC: 10590480. DOI: 10.7759/cureus.45749.


Statistical fundamentals on cancer research for clinicians: Working with your statisticians.

Xu W, Huang S, Su J, Gudi S, OSullivan B Clin Transl Radiat Oncol. 2021; 27:75-84.

PMID: 33532634 PMC: 7829109. DOI: 10.1016/j.ctro.2021.01.006.


Randomized Trial of an Intervention to Improve Blood Pressure Control in Stroke Survivors.

Owolabi M, Gebregziabher M, Akinyemi R, Akinyemi J, Akpa O, Olaniyan O Circ Cardiovasc Qual Outcomes. 2019; 12(12):e005904.

PMID: 31805787 PMC: 7139215. DOI: 10.1161/CIRCOUTCOMES.119.005904.


Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.

Yang S, Starks M, Hernandez A, Turner E, Califf R, OConnor C Contemp Clin Trials. 2019; 88:105775.

PMID: 31228563 PMC: 8337048. DOI: 10.1016/j.cct.2019.04.016.


A comparison of methods to adjust for continuous covariates in the analysis of randomised trials.

Kahan B, Rushton H, Morris T, Daniel R BMC Med Res Methodol. 2016; 16:42.

PMID: 27068456 PMC: 4827223. DOI: 10.1186/s12874-016-0141-3.

References
1.
Beach M, Meier P . Choosing covariates in the analysis of clinical trials. Control Clin Trials. 1989; 10(4 Suppl):161S-175S. DOI: 10.1016/0197-2456(89)90055-x. View

2.
Senn S . Testing for baseline balance in clinical trials. Stat Med. 1994; 13(17):1715-26. DOI: 10.1002/sim.4780131703. View

3.
Blackwelder W . "Proving the null hypothesis" in clinical trials. Control Clin Trials. 1982; 3(4):345-53. DOI: 10.1016/0197-2456(82)90024-1. View

4.
Senn S . Covariate imbalance and random allocation in clinical trials. Stat Med. 1989; 8(4):467-75. DOI: 10.1002/sim.4780080410. View

5.
Ford I, Norrie J, Ahmadi S . Model inconsistency, illustrated by the Cox proportional hazards model. Stat Med. 1995; 14(8):735-46. DOI: 10.1002/sim.4780140804. View